Teva Pharmaceutical News
Most Popular Teva Pharmaceutical Story
Why is Ratiopharm suddenly so popular?
Are low interest rates prompting the big interest in Ratiopharm? That's one explanation analysts have hit on in trying to explain Pfizer's newfound zeal at the prospect of buying the German generics... Read more...
Latest Headlines
- March 19, 2010
- March 18, 2010
- March 17, 2010
- March 10, 2010
- March 9, 2010
- March 3, 2010
- March 3, 2010
- February 18, 2010
- February 17, 2010
- February 16, 2010
- February 16, 2010
- February 3, 2010
- February 1, 2010
- January 27, 2010
- January 27, 2010
- January 25, 2010
- January 19, 2010
- January 8, 2010
- January 7, 2010
- January 4, 2010
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
